Methods for the treatment of dementia based on ApoE genotype

Details for Australian Patent Application No. 2003266967 (hide)

Owner Novartis AG

Inventors Polymeropoulos, Mihael Hristos; Lane, Roger Michael

Agent Davies Collison Cave

Pub. Number AU-B-2003266967

PCT Number PCT/EP03/08719

PCT Pub. Number WO2004/015140

Priority 60/401,694 07.08.02 US

Filing date 6 August 2003

Wipo publication date 25 February 2004

Acceptance publication date 16 November 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 31/27 (2006.01)

Event Publications

8 January 2004 Complete Application Filed

  Priority application(s): 60/401,694 07.08.02 US

8 April 2004 Application Open to Public Inspection

  Published as AU-B-2003266967

16 November 2006 Application Accepted

  Published as AU-B-2003266967

15 March 2007 Standard Patent Sealed

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003266968-IN-SITU PRODUCTION OF SUSPENSION CONCENTRATE OF DIPHENYL ETHER AND N- (PHOSPHONO-METHYL)GLYCINE OR HOMOALANINYLMETHYL-PHOSPHINATE HERBICIDAL COMPOSITIONS AND METHODS OF USE

2003266966-Process for preparing nitrooxyderivatives of naproxen